Benzodiazepine-Related DisordersESUBNCT06467019
Informative Exhibition for Deprescribing Benzodiazepines
An observational study of Benzodiazepine-Related Disorders, run by Consorci Sanitari de l'Alt Penedès i Garraf at 1 site in Spain.
Trial summary
The goal of this trial is to determine if an interactive and informative exhibition in the waiting room of a Primary Care Clinic can reduce the use of benzodiazepines in adults. The main question it aims to answer is: Does an interactive and informative exhibition reduce the number of participants using… Read more about this study
- Who is it for?
- Ages 18 to 99 years
- Conditions the study is for
- Benzodiazepine-Related Disorders
- What is being tested?
- Informative Session
- How many people
- 6,410 participants
- Where
- 1 siteSpain
- Study dates
- 13 Jun 2024to Jul 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 99 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Community population assigned to a primary care center.
Who may be able to join
- Men and women between 18 and 99 years of age.
- Attended at the Baix-a-Mar Primary Care Center during the study period.
Who cannot join
- Severe mental health disease
- Displaced patients or those who do not have an assigned doctor at the center.
- Participation in another study involving an experimental intervention during the period of the present study that affects benzodiazepine prescription.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Spain1 site, 1 recruiting
- Recruiting
Centro de Salud Vilanova i la Geltrú 3 Baix A Mar
Vilanova i la Geltrú, Barcelona
Jordi Milozzi, MD, +34 938 10 30 03, jmilozzi@csapg.cat
Noemí Casaponsa, +34 938960026 ext. 43197, recerca@csapg.cat
About this study
Official title: Impact of an Interactive and Informative Exhibition on Benzodiazepine Use on Deprescription.
The goal of this trial is to determine if an interactive and informative exhibition in the waiting room of a Primary Care Clinic can reduce the use of benzodiazepines in adults. The main question it aims to answer is:
- Does an interactive and informative exhibition reduce the number of participants using benzodiazepines? Researchers will compare benzodiazepine consumption before and after the interactive and informative exhibition implementation at study center.
Participants will receive an informative and interactive exhibition on the risks of chronic benzodiazepine use. A single informative session on the same topic will be conducted for health professionals.
- Conditions
- Benzodiazepine-Related Disorders
- Being tested
- Informative Session
- Keywords
- Benzodiazepines, Deprescriptions
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Informative SessionOther
The intervention consists of implementing an interactive exhibition on the risks of chronic benzodiazepine treatment in the waiting room of a primary care center. Additionally, the health professionals at the center will receive a single informative session on the same topic.
| Study group | Role | What they receive |
|---|---|---|
| Before intervention | This group will consist of patients who attended the primary care center before the implementation of the intervention. | |
| After intervention | This group will consist of patients who will attend the primary care center after the implementation of the intervention. Receives: Other: Informative Session |
What is being measured
The primary outcome is the main question the study is designed to answer.
Chronic treatment with benzodiazepines
Percentage of patients treated chronically with benzodiazepines, based on electronic prescription data.
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Jun 2024
- Study start13 Jun 2024
- Primary completionJul 2027 (estimated)
- Study completionJul 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Benzodiazepine-Related DisordersStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Other
- Enrolment
- 6,410 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Consorci Sanitari de l'Alt Penedès i Garraf
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Jordi Milozzi, MD, Principal investigator, Centro de Salud Vilanova i la Geltrú 3 Baix A Mar-CSAPG
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06467019
- Sponsor's protocol ID
- CSAPG-59
- Acronym
- ESUB
- Status last verified
- Oct 2026
- First submitted
- 14 Jun 2024
- Last updated
- 27 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: IPD (without personal identification data) could be shared by requirement from other researchers after the end of the study, and only for research purposes and previous approval of promotor center of the study (CSAPG). Anyway, Spanish and European Union legal policy about data protection will strictly be followed (IPD will not be transferred outside European Union).
Study at a glance
From the registry record, last updated by the sponsor on 27 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Impact of an Interactive and Informative Exhibition on Benzodiazepine Use on Deprescription.
- ClinicalTrials.gov ID
- NCT06467019
- Acronym / sponsor ID
- ESUB / CSAPG-59
- Conditions
- Benzodiazepine-Related Disorders
- Keywords
- Benzodiazepines, Deprescriptions
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 6,410 participants (estimated)
- Lead sponsor
- Consorci Sanitari de l'Alt Penedès i GarrafUniversity, hospital or other
- Study start
- 13 Jun 2024 (actual)
- Primary completion
- Jul 2027 (estimated)
- Study completion
- Jul 2027 (estimated)
- First posted
- 20 Jun 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this trial is to determine if an interactive and informative exhibition in the waiting room of a Primary Care Clinic can reduce the use of benzodiazepines in adults. The main question it aims to answer is:
- Does an interactive and informative exhibition reduce the number of participants using benzodiazepines? Researchers will compare benzodiazepine consumption before and after the interactive and informative exhibition implementation at study center.
Participants will receive an informative and interactive exhibition on the risks of chronic benzodiazepine use. A single informative session on the same topic will be conducted for health professionals.
Study design
- Observational model
- Other
- Time perspective
- Other
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Before intervention | – | –This group will consist of patients who attended the primary care center before the implementation of the intervention. |
| After intervention | – | Other: Informative SessionThis group will consist of patients who will attend the primary care center after the implementation of the intervention. |
Who may qualify
- Ages
- 18 to 99 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Community population assigned to a primary care center.
Key inclusion criteria (2 listed)
- Men and women between 18 and 99 years of age.
- Attended at the Baix-a-Mar Primary Care Center during the study period.
Key exclusion criteria (3 listed)
- Severe mental health disease
- Displaced patients or those who do not have an assigned doctor at the center.
- Participation in another study involving an experimental intervention during the period of the present study that affects benzodiazepine prescription.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Informative SessionThe intervention consists of implementing an interactive exhibition on the risks of chronic benzodiazepine treatment in the waiting room of a primary care center. Additionally, the health professionals at the center will receive a single informative session on the same topic. | Other | After intervention |
Primary outcome
Chronic treatment with benzodiazepines
Time frame: 1 year
Percentage of patients treated chronically with benzodiazepines, based on electronic prescription data.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Oct 2026.
- Individual participant dataSharing planned: Yes. IPD (without personal identification data) could be shared by requirement from other researchers after the end of the study, and only for research purposes and previous approval of promotor center of the study (CSAPG). Anyway, Spanish and European Union legal policy about data protection will strictly be followed (IPD will not be transferred outside European Union).
Related trials for Benzodiazepine-Related Disorders
Recruiting
Brief Motivational Intervention (BMI) on the Deprescription of Benzodiazepines and Related Substances in Adult Chronic Drug Users
Benzodiazepine Withdrawal
Recruiting
Flumazenil for Benzodiazepine Reversal in Electroconvulsive Therapy
Depression - Major Depressive Disorder, Bipolar Disorder (BD)
RecruitingPhase 2
Opioid/Benzodiazepine Polydrug Abuse: Aim 3
Opioid Abuse, Benzodiazepine Abuse
RecruitingObservational study
Opioid/Benzodiazepine Polydrug Abuse
Polysubstance Abuse
Active, not recruitingObservational study
Treatment Outcomes Among Patients With Prescription Narcotic Drug Use Disorder
Drug Use Disorders
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Jordi Milozzi, MD principal investigator
Centro de Salud Vilanova i la Geltrú 3 Baix A Mar-CSAPG
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Benzodiazepine-Related Disorders, run by Consorci Sanitari de l'Alt Penedès i Garraf at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 27 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Jordi Milozzi, MD (+34 938 10 30 03, jmilozzi@csapg.cat), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Chronic treatment with benzodiazepines (time frame: 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Oct 2026.